ArticleWorld journal of gastrointestinal oncology2025
Correlation between sarcopenia diagnosed by C3SMI criteria and prognosis in esophageal cancer patients after radiotherapy.
Article in World journal of gastrointestinal oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEsophageal cancer is a common malignancy with high mortality. Radiotherapy is an important treatment. Sarcopenia affects patients' physical function and prognosis. However, the relationship between sarcopenia diagnosed by Chun-Hou Chen method for sarcopenia measurement and index (C3SMI) criteria and esophageal cancer prognosis after radiotherapy is unclear.
aimTo explore the correlation between sarcopenia (SA) diagnosed based on C3SMI criteria and the prognosis of patients with esophageal cancer following radiotherapy.
methodsA retrospective analysis was conducted on the general clinical data of 131 esophageal cancer patients who received radiotherapy in the Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University from March 2021 to July 2024. Based on the presence of SA, the patients were assigned into two groups - the SA group and the non-SA group. Logistic regression analysis was used for investigating the risk factors influencing SA in esophageal cancer patients. Additionally, the patients were followed up, with their prognosis recorded. As per their prognostic outcomes, the patients were allocated into a good prognosis group and a poor prognosis group. The data of the two groups were compared. Using logistic regression analysis, the risk factors that may influence the prognosis of these patients were analyzed. SPSS 26.0 statistical software was introduced for analyzing the study data. Comparisons were made between groups using
resultsAs revealed through logistic regression analysis, age [odds ratio (OR) = 2.898,
conclusionThe presence of SA has a significant relation to the poor prognosis of esophageal cancer patients, which highlights the importance of assessing and intervening in SA in clinical management so as to improve patient prognosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.